Optic nerve astrocytoma
diseaseOn this page
Also known as astrocytic tumour of optic nerveastrocytoma (excluding glioblastoma) of cranial nerve IIastrocytoma of optic nerveastrocytoma of the optic nervecranial nerve II astrocytoma (excluding glioblastoma)optic tract astrocytomaoptic tract astrocytoma (excluding glioblastoma)
Summary
Optic nerve astrocytoma (MONDO:0003234) is a disease. A subtype of malignant cranial nerve neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | optic nerve astrocytoma |
| Mondo ID | MONDO:0003234 |
| DOID | DOID:4991 |
| NCIT | C6769 |
| UMLS | C1335114 |
| MedGen | 235405 |
| GARD | 0023416 |
| Anatomy (UBERON) | UBERON:0000941 |
| Is cancer (heuristic) | no |
Also known as: astrocytic tumour of optic nerve · astrocytoma (excluding glioblastoma) of cranial nerve II · astrocytoma of optic nerve · astrocytoma of the optic nerve · cranial nerve II astrocytoma (excluding glioblastoma) · optic nerve astrocytoma · optic tract astrocytoma · optic tract astrocytoma (excluding glioblastoma)
Disease family
Classification path: disease › human disease › disease by body system or component › nervous system disorder › peripheral nervous system disorder › peripheral nervous system neoplasm › cranial nerve neoplasm › malignant cranial nerve neoplasm › optic nerve astrocytoma
Related subtypes (4): malignant neoplasm of acoustic nerve, oculomotor nerve cancer, olfactory neuroblastoma, malignant olfactory nerve neoplasm
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.